Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 279

1.

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K, Pomerantz RJ.

N Engl J Med. 1998 Dec 17;339(25):1803-9.

PMID:
9854115
[PubMed - indexed for MEDLINE]
Free Article
2.

Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.

Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ.

AIDS. 2002 Jan 4;16(1):39-45.

PMID:
11741161
[PubMed - indexed for MEDLINE]
3.

Seminal reservoirs during an HIV type 1 eradication trial.

Nunnari G, Leto D, Sullivan J, Xu Y, Mehlman KE, Kulkosky J, Pomerantz RJ.

AIDS Res Hum Retroviruses. 2005 Sep;21(9):768-75.

PMID:
16218800
[PubMed - indexed for MEDLINE]
4.

Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM.

N Engl J Med. 1999 May 27;340(21):1614-22.

PMID:
10341273
[PubMed - indexed for MEDLINE]
Free Article
5.

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, Fiscus SA, Cohen MS.

AIDS. 1998 Oct 22;12(15):F181-9.

PMID:
9814860
[PubMed - indexed for MEDLINE]
6.

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, Talal A, Racz P, Perelson AS, Korber BT, Markowitz M, Ho DD.

N Engl J Med. 1999 May 27;340(21):1605-13.

PMID:
10341272
[PubMed - indexed for MEDLINE]
Free Article
7.

Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission.

Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C.

AIDS. 1999 May 7;13(7):823-31.

PMID:
10357382
[PubMed - indexed for MEDLINE]
8.

Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.

Andreoni M, Parisi SG, Sarmati L, Nicastri E, Ercoli L, Mancino G, Sotgiu G, Mannazzu M, Trevenzoli M, Tridente G, Concia E, Aceti A.

AIDS. 2000 Jan 7;14(1):23-9.

PMID:
10714564
[PubMed - indexed for MEDLINE]
9.

Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.

Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ.

Clin Infect Dis. 1999 Jun;28(6):1252-9.

PMID:
10451162
[PubMed - indexed for MEDLINE]
Free Article
10.

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.

Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, Boggian K, Cohen MS, Fiscus SA, Eron JJ.

AIDS. 2000 Jan 28;14(2):117-21.

PMID:
10708281
[PubMed - indexed for MEDLINE]
11.

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM.

N Engl J Med. 2001 Feb 15;344(7):472-80.

PMID:
11172188
[PubMed - indexed for MEDLINE]
Free Article
12.

Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC.

J Infect Dis. 2001 Jan 1;183(1):36-50. Epub 2000 Dec 8.

PMID:
11106537
[PubMed - indexed for MEDLINE]
Free Article
13.

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Otero M, Nunnari G, Leto D, Sullivan J, Wang FX, Frank I, Xu Y, Patel C, Dornadula G, Kulkosky J, Pomerantz RJ.

AIDS Res Hum Retroviruses. 2003 Dec;19(12):1097-103.

PMID:
14709246
[PubMed - indexed for MEDLINE]
14.

HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.

Russell RR, Bowmer MI, Nguyen C, Grant MD.

Viral Immunol. 2001;14(4):379-89.

PMID:
11792067
[PubMed - indexed for MEDLINE]
15.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
[PubMed - indexed for MEDLINE]
16.

Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).

Leruez-Ville M, Dulioust E, Costabliola D, Salmon D, Tachet A, Finkielsztejn L, De Almeida M, Silbermann B, Sicard D, Jouannet P, Rouzioux C.

AIDS. 2002 Feb 15;16(3):486-8. No abstract available.

PMID:
11834963
[PubMed - indexed for MEDLINE]
17.

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF.

Science. 1997 Nov 14;278(5341):1295-300.

PMID:
9360927
[PubMed - indexed for MEDLINE]
Free Article
18.

Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.

Vitone F, Gibellini D, Schiavone P, Re MC.

J Clin Virol. 2005 Jul;33(3):194-200. Epub 2004 Dec 15.

PMID:
15911440
[PubMed - indexed for MEDLINE]
19.

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW.

J Infect Dis. 2001 Jan 1;183(1):23-35. Epub 2000 Dec 8.

PMID:
11106536
[PubMed - indexed for MEDLINE]
Free Article
20.

HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.

Re MC, Vitone F, Biagetti C, Schiavone P, Alessandrini F, Bon I, de Crignis E, Gibellini D.

Clin Microbiol Infect. 2010 Jun;16(6):640-6. doi: 10.1111/j.1469-0691.2009.02826.x. Epub 2009 Sep 2.

PMID:
19732081
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk